Alzamend Neuro Inc. (ALZN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Alzamend Neuro Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.19
+5.31% today
Market cap
$5M
Overall quality
59/100
Kronos AI 30-day
+10.3%
8 of 8 simulated paths end higher
Alzamend Neuro Inc. (ALZN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $5M. It trades at $1.19, up 5.31% today. Its overall quality score is 59 out of 100, ranked against the whole US market. 1 analysts' average target of $26.00 implies +2084.9% from today's price. Kronos AI's 30-day forecast is +10.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $26.00 |
| Low – high | $26.00 – $26.00 |
| Analysts | 1 |
| Upside to average | +2084.9% |
Kronos AI 30-day forecast
| Expected close | $1.25 (+10.3%) |
| Likely range | +3.9% … +16.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 36 |
| Solvency | 93 |
| Growth | 48 |
| Overall | 59 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.